CVS Health’s iShares 1-5 Year Investment Grade Corporate Bond ETF IGSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.6M Buy
890,000
+595,600
+202% +$31.2M 20.72% 1
2026
Q1
$15.5M Buy
294,400
+200,000
+212% +$10.6M 7.29% 4
2025
Q4
$4.99M Buy
+94,400
New +$5M 3.69% 5

Other funds holding IGSB

CVS Health's IGSB Position: Q2 2026 in Review

CVS Health increased its iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) stake by 202% in Q2 2026, buying an estimated $31.2M and bringing the position to 890,000 shares worth $46.6M. The position accounts for 20.72% of the portfolio, ranked #1.

CVS Health first reported a position in IGSB in Q4 2025 and has held it in 3 quarters since. 1,002 funds tracked by Wall St. Rank hold IGSB as of Q2 2026.

  • CVS Health held 890,000 shares of iShares 1-5 Year Investment Grade Corporate Bond ETF worth $46.6M as of Q2 2026.
  • CVS Health bought 595,600 iShares 1-5 Year Investment Grade Corporate Bond ETF shares in Q2 2026, an estimated $31.2M.
  • iShares 1-5 Year Investment Grade Corporate Bond ETF made up 20.72% of CVS Health's portfolio in Q2 2026, its #1 holding.
  • CVS Health first reported a position in iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2025 and has held it in 3 quarters since.
  • 1,002 funds tracked by Wall St. Rank held iShares 1-5 Year Investment Grade Corporate Bond ETF as of Q2 2026.

Based on CVS Health's 13F filing for Q2 2026, filed 6 Aug 2026.